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A significant proportion of the global population regularly experience air quality poorer than 
that recommended by the WHO. Air pollution, especially fine particulate matter (PM2.5) is a 
risk factor for various non-communicable diseases and is emerging as a risk factor for 
dementia. To begin to understand the full impact of PM2.5  we review the longitudinal 
epidemiological evidence linking PM2.5  to both dementia and to other leading non-
communicable diseases and highlight the evidence gaps. 
Our objective was to systematically review the current epidemiological evidence for PM2.5 as 
a risk factor for cognitive-decline and incident dementia and to put this in context with a 
systematic overview of PM2.5 as a potential risk factor in other leading NCDs, 
Methods  
We performed two systematic reviews. A high level review of reviews examining the 
relationship between PM2.5 and leading NCDs and an in-depth review of the longitudinal 
epidemiological data examining relationships between PM2.5 incident dementia and cognitive 
-decline.  
Results  
There were robust associations between PM2.5 and NCDs although in some cases the 
evidence was concentrated on short rather than longer-term exposure. For those articles 
reporting on incident dementia, all reported on longer-term exposure and five of the seven 




The evidence base for PM2.5 as a risk factor for dementia is growing. It is not yet as strong as 
that for other NCDs. However, varied measurement/methodology hampers clarity across the 
field. We propose next steps.  
 
Keywords  







In recent years the established literature linking poor air quality to adverse cardiopulmonary 
endpoints, including excess mortality [1], has expanded to include evidence of associations 
with incident dementia [2-4]. In 2018 we reviewed the evidence for air pollution and cognitive 
decline or dementia and noted that these adverse associations appear strongest when 
considering long-term exposures to ambient fine particulate matter (PM2.5). PM2.5 refers to 
particles with an average aerodynamic diameter of ≤2.5 µm and is composed of a mixture of 
chemical components, primary emissions and products of secondary chemical reactions in 
the atmosphere, derived from a wide range of sources [5, 6]. The PM2.5 ambient mass 
concentration, averaged over varying lengths of time, reflects the sum of all these sources 
and provides a single uniform metric to interrogate population health, often based on 
modelled attributions, but ultimately informed by widespread monitoring of this pollutant for 
regulatory and research purposes. Globally the World Health Organization (WHO) estimates 
that around 91% of the population live in places where annual fine particulate matter (PM2.5) 
levels regularly exceed the recommended WHO guideline level of 10 µg/m3, with those in 
low and middle income countries most at risk [3].  
Importantly, there are also established links between leading Non-Communicable Diseases 
(NCD) (for example diabetes and stroke) and an increased risk of later dementia [5]. This is 
important since PM2.5 may raise risk of dementia via both direct and indirect pathways. For 
example, dementia risk may be increased via inflammatory respiratory disease pathways 
and/or cerebrovascular disease. [6, 7]. Given the potential overlap between PM2.5 as a risk 
factor for NCDs and a fast emerging risk factor for dementia, it is important to understand its 
population level impact: Here we draw together the epidemiological evidence linking PM2.5 
exposure to incident leading NCDs  (using review of review methodology) and also 
systematically review the longitudinal epidemiological evidence on the relationship between 
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PM2.5 and incident dementia and cognitive decline. We present the extent and scope of the 
evidence to date, highlighting the gaps and proposing the next steps.   
METHODS 
Standard systematic review methodology [8] was used to undertake two complementary  
literature searches. The first was a high-level systematic update focused on PM2.5 as a risk 
factor for leading NCDs followed by an in-depth systematic review examining the relationship 
between PM2.5 and incident cognitive decline and dementia. For both reviews there were two 
independent analysts (RP, JP). The lead analyst carried out the literature searches. All 
identified abstracts, or titles where abstracts were unavailable, were double reviewed and a 
list of potentially relevant references compiled independently by the two analysts. These lists 
were compared, and differences were resolved by discussion. Once the list of possible 
references was agreed, full text articles were obtained, independently read and assessed for 
relevance. Data were extracted by the lead analyst and checked by the 2nd analyst. Standard 
extraction tables were used.  
Major non-communicable disease and PM2.5 
Leading NCDs were defined as cardiovascular disease (myocardial infarction, heart failure, 
stroke), respiratory disease (COPD, asthma), lung cancer, diabetes mellitus or Chronic 
Kidney Disease (CKD), based on the WHO top 10 NCD causes of death [9]. To evaluate the 
relationship between exposure to PM2.5 and leading NCDs, the databases MEDLINE, 
Embase and PsycInfo® were searched from inception to 31st January 2020. A review of 
reviews methodology was selected as a systematic method frequently used to summarise 
large volumes of data from an established literature and to ensure inclusion of most 
comprehensive and recent evidence [10, 11]. Search terms included (air pollut* or particulate 
or PM10 or PM2 5 or Roadway or Vehicle or Diesel.ti.)  and (systematic review.ti or 
systematic.af)) (supplementary text 1). Utilising methodologies adapted from those that 
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underpin guideline development [12], we included only the most recent systematic review 
reporting on incident or worsening NCD and exposure to PM2.5. We did not include cross 
sectional relationships, diagnoses that may predispose to NCDs (e.g. insulin resistance, 
hypertension, obesity), data from child or adolescent populations, those reporting composite 
outcomes or solely fatal outcomes. Data were extracted from the systematic reviews on the 
number of constituent studies, the regions of the world where the studies had taken place, 
the way the exposure had been assessed, the PM2.5 exposure estimates for the population, 
the assessment of incident disease and the results.    
The Assessing the Methodological quality of Systematic reviews (AMSTAR) version two 
(https://amstar.ca/Amstar-2.php) was used to evaluate the systematic reviews [13]. 
 
Dementia, cognitive decline and PM2.5   
To evaluate the relationship between exposure to PM2.5 and incident cognitive decline or 
dementia (including incident Alzheimer’s Disease), the databases MEDLINE, Embase and 
PsycInfo® were searched from 2018 to April 1st 2020, supplemented by a prior search from 
inception to September 2018 [14]. Search terms included (alzheime* or dementia or cogniti*) 
and (air pollut* or particulate matter or roadway or Particle Size or PM* or vehicle or diesel) 
(supplementary text 1). The results were further strengthened using forward citation 
searching for each of the included articles published prior to September 2018 and examining 
each citing article against the inclusion and exclusion criteria.  Articles were included if they 
reported on longitudinal studies evaluating the relationship between exposure to outdoor 
PM2.5 and incident cognitive decline or dementia, in human adults aged 18 years and older. 
Studies reporting indoor exposure or examining passive smoking were excluded. Where 
more than one article reported on the same population the article including the largest 
number of participants was included.  
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For the relationship between PM2.5 and incident cognitive decline or dementia (including 
Alzheimer’s Disease) information was collected on the dates of exposure, duration of follow 
up, assessment of incident cognitive decline or dementia, PM2.5 concentrations, region of the 
world where the studies had taken place and the results. Where multiple results were 
available the most conservative interpretation, i.e. selecting the longest exposure and most 
adjusted model, was reported. Data were extracted on length, dates and measures of 
exposure, region of recruitment, number of participants and participant age, average PM2.5 
level, assessment of dementia or cognitive decline, results and evaluation of potential 
confounders.  
Each original research article was also assessed for bias against key criteria based on the 
Critical Appraisal Skills Programme (CASP©) cohort study checklist [15] and potential 
sources of bias in each study were tabulated.  
 
RESULTS  
Major non-communicable disease and PM2.5 
For the searches of systematic reviews reporting on the relationship between exposure to 
PM2.5 and incident NCD, 799 abstracts were screened and 30 assessed at full text stage. 
Twenty-two were excluded after full text screening. Sixteen of these reviews had been 
superseded by more recent reviews, two were of the same year as alternative reviews, but 
more limited.  In one review it was not possible to separate out the results for adults and 
children, one did not separate out PM2.5, one did not exclude cross sectional data and one 
focused on methodology, Supplementary table 1. No reviews were excluded based on their 
assessment of exposure (duration or methodology). Figure 1 for a flow chart. Reviews 
included case control, cross-over and time series studies with two [16] to 59 [17] studies 
included in meta-analyses.  
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Systematic reviews were identified that reported on the association between PM2.5 and 
incident or exacerbated respiratory disease ((lung cancer [18] chronic obstructive airways 
disease (COPD) [17], asthma [19]), diabetes mellitus (DM) [20], cardiovascular disease 
(heart failure [21], stroke [22], myocardial infarction (MI) [23]) and chronic kidney disease 
(CKD) [16]. (Table 1). Follow-up was both long term (3-34 years for the constituent studies 
on lung cancer [18]), 1-10 years for DM [20], 2 years for CKD [16] and short term with acute 
exposures of 0-3 days for COPD [17] and 0-7 days for stroke, heart failure, MI and asthma 
[21, 23, 22, 19]. All meta-analyses reported a statistically significant relationship between 
their respective outcome and 10 µg/m3 increment in PM2.5 with most point estimates falling 
between a one and 10 percent increase in risk.  See table 1 (In brief, estimated percentage 
increase and 95% confidence intervals from meta-analyses, for lung cancer 9 (4-14), COPD 
2 (1-4) asthma 3 (1-5), DM 10 (4-17) heart failure 112 (42-182), MI 2 (2-3), stroke 1 (1-1)) 
 
Dementia, cognitive decline and PM2.5   
For the searches relating to the relationship between exposure to PM2.5 and incident 
cognitive decline or dementia (2018-present), 439 abstracts were screened and 14 assessed 
at the full text stage. Ten were excluded after full text screening (supplementary table 2), one 
did not report results for PM2.5, three either included prevalent dementia, or it was not 
possible to tell whether it was excluded, one reported only fatal outcomes, three appeared to 
report on sub-populations of studies already included and two reported cross temporal 
analyses without measuring incident decline. Four articles were included ([24-27]) and these 
were supplemented with nine articles that had been identified in our prior systematic review 
(covering the literature from inception to 2018) but which also met inclusion criteria the [28-
36] Tables 2 and 3 and figure 1 for the flow chart.  
9 
 
Seven studies reported on incident dementia [31-34, 36, 25, 27] (Table 2) Five of the seven 
studies reporting on incident dementia used administrative health records for case 
ascertainment, selecting out coded incident dementia based on the International 
Classification of Disease codes versions 9 or 10 ([31, 33, 34, 27], Read codes (used in UK 
general practice) [34] and/or the Diagnostic Statistical Manual version 4 (DSM IV) [31, 36]. 
The three smallest studies were research cohorts. These included: i) the Betula cohort from 
Sweden (n=1806) [36], which reported additional review by old age psychiatrist, for dementia 
diagnosis, ii) the Swedish National Study on Ageing and Care in Kungsholmen (SNAC-K) 
(n=2927), which used physician review [25] and iii) the Cacciolotto et al study population 
(n=3647), which was drawn from the larger Women’s Health Initiative Memory (WHIMS) 
Study [32]. WHIMS was a research-based cohort with repeated assessments that diagnosed 
dementia with a multi-step process using the extended Mini-Mental State Examination 
(MMSE) for screening. Those that screened positive received further neuropsychological 
and physician assessment plus imaging. [32] The studies that used health records were 
population based and reported on between 100,000 and over 2 million individuals [31, 33, 
34, 27]. Although age was not consistently reported, the mean baseline age for all dementia 
studies was estimated at around 65 years. Exposure duration ranged from one [34] to 14 
years [33] with PM2.5 data collected at different time points from 1990 [36] to 2012 [33]. Five 
of the seven studies reported a relationship between exposure to PM2.5 and increased risk of 
incident dementia, but methodology varied between studies.  Exposure was based around 
residential location, with several studies specifying details such as the use of postcodes or 
zip codes [31, 33] taking account of the history as well at the present residential location 
[32], or use of grids as small as 50m x 50m in urban areas and 3200m x 3200m in rural 
areas [36]. Annual exposure measures were most common [32-34, 36] but exact measures, 
timing and calculation of exposure variables differed. The USA study [32] reported a 92% 
(Hazard Ratio (HR)1.92 (95% Confidence Interval (CI) 1.31:2.80) increased risk for exposure 
to levels above 12 µg/m3 over 3 years, the Canadian study reported a 3% (HR1.03 
(1.02:1.05)) increased risk with an increment of 4.8 µg/m3 [33], the UK study a 6% (HR1.06 
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(1.01:1.13)) increased risk but for a 0.95 µg/m3 incremental change in exposure [34] and one 
Swedish study a 54% (HR1.54 (1.33:1.78)) increased risk per 0.88 µg/m3 increase.[25] The 
other studies found no increased risk including the Taiwanese study [31] which reported 
exposure measures of 33.6 µg/m3 and the study with the lowest concentrations, the Betula 
study reporting a mean annual average PM2.5  concentration of 0.18 µg/m3 (Standard 
Deviation (SD) 0.17 µg/m3). [36] 
The seven studies reporting on incident cognitive decline all comprised research cohorts, 
(Table 2). Two were recruited from the UK [30, 24] and five from the USA[28, 29, 32, 35, 26]. 
Studies ranged in size from 2048 [35] to over 20,000 [29] participants. Air pollution measures 
were collected as early as 1988 [28] and as recently as 2010 [32, 24] [26]. The mean age of 
the cohorts ranged from 56.9 (SD 8.1) [24] to 76.3 (SD 6.6) [26] years. All reported on 
cognitive change or incident decline defined as a fall to below a threshold [29] or of a certain 
size [32]. Some chose to report cognitive domains or general cognitive assessment and 
three used screening tools [29, 35], [32]. The relationships between air pollution and 
cognition were largely non-significant [29, 30, 24], [35]. The exceptions were Weuve et al 
who reported a significant 2-yr decrease in global cognitive z-score (per 10 µg/m3 increase in 
PM2.5) [28] and the WHIMS cohort which found an 81% (HR1.81 (1.42:2.32)) increase in 
incident cognitive decline (an 8 point decline in extended mini-mental state exam in 2 
consecutive assessments) in the higher exposure group [32].  Levels of PM2.5 were similar 
across studies with mean concentrations of 14.9 [30]14.2 [28], 13.6 (Median) [29], 13.5 [26], 
9.7 [35] and 9.6 [24] µg/m3. 
 
Assessment of bias  
Overall the risk of bias within studies reporting on the relationship between PM2.5 and 
incident dementia, or cognitive decline was low to moderate (six rated as low, six as low-
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moderate and one as moderate) See supplementary table 3. Included studies reported clear 
aims, appropriate methodology, comprehensive adjustment for confounders, standard 
methods for measurement of exposure and use of health records or appropriate cognitive 
testing for outcomes. Improvements within individual studies would involve improving 
detailed assessment of exposure, using more comprehensive neuropsychological testing 
and more rigorous case ascertainment, selecting more representative populations and 
investigating attrition more thoroughly. For NCDs the reviews were largely rated as moderate 
quality using the rigorous AMSTAR 2 criteria [13] (six as moderate and two low quality).  
Across the evidence base  
A greater risk of bias becomes evident when the studies are narratively synthesized and 
considered together as a body of research [37]. For the studies on dementia and cognitive 
decline, although the evidence is largely from older adults, the differing lengths of exposure, 
methods of modelling of exposure and outcome and varied combinations of confounders and 
potential under or over adjustment in the analyses (we selected the most adjusted results) 
make the studies appear less comparable than when assessed individually. For example, it 
is not possible to know whether the same positive or negative relationships would be shown 
across the studies if the same PM2.5 concentrations and exposure times had been used. 
Data are also drawn only from a limited number of high-income countries and are lacking for 
younger age groups and longer-term follow-up, particularly relevant for dementia where 
disease processes may start 10 or 20 years prior to symptom onset [38]. The reviews of 
other NCDs suffer from similar issues with some evidence only available for acute and very 
short-term exposure and some only for on longer-term follow up measures. Reviews 
demonstrate more global data than the studies of dementia, but most combine varied study 
designs and wide PM2.5 concentration ranges. Finally, for all review and original research 
studies, included in this systematic review, PM2.5  was defined based on its ambient mass 
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concentration, which is insensitive to the significant regional differences in its composition 
[39-42].   
 
DISCUSSION  
Our aim was to systematically review the evidence relating to PM2.5 and risk of dementia or 
cognitive decline, and to position this within a wider public health context. In addition, given 
that vascular disease itself is a risk factor for dementia [6, 7], we also performed a 
systematic review of the evidence for PM2.5 and other relevant NCDs, to contextualise these 
observations with other established diseases previously associated with PM2.5 exposures 
and sharing common underlying inflammatory pathways. 
Overall, for studies on cognition, we found that the evidence supporting an association 
between fine particulate matter exposures was strongest for dementia. Studies on cognitive 
decline were inconclusive, with only two of the seven studies reporting an elevated risk both 
of which used general measures of cognition. In contrast, most of the studies on incident 
dementia demonstrated an increased risk with higher PM2.5 concentrations. Our results are 
broadly in agreement with prior reviews [43-45]. The systematic review evidence for the 
other NCDs was clearer than the evidence for cognition and dementia, however, exposure 
times for some outcomes were effectively based on acute time periods, whereas others were 
over the longer term. Interestingly the results for dementia outcomes were obtained despite 
most studies adjusting broadly for the presence of other cardiovascular co-morbidities, which 
may support an independent PM2.5  dementia pathway. This potentially argues for a more 
direct linkage to Alzheimer’s disease as opposed to vascular dementia, but this distinction 
needs further research beyond inference drawn from epidemiological observations.  
Using standard review methodology, we used published data and, in order to represent the 
evidence base on NCDs, selected a review of reviews method rather than reviewing primary 
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research. Despite this, we undertook a rigorous systematic review approach and, whilst we 
can conclude that the emerging evidence base confirms that PM2.5 is associated with 
increased risk of dementia and other NCDs, consideration of the whole picture reveals 
several limitations.  
Individual studies and reviews revealed no definitive sources of bias on formal assessment, 
however, when considered holistically the gaps in the evidence become clearer. We raise 
several issues that need to be addressed before using the evidence to inform the detail for 
policy or planning These limitations fall within three categories:  i) those that may be 
overcome in the shorter term, ii) those that require additional research and iii) those that 
cannot be easily remedied without additional data collection. We discuss each of these and 
make recommendations below.  
(1) Limitations that may be overcome in the shorter term. These include a lack of 
standardisation in reporting and in analyses, varied adjustment for confounders, the 
potential for incomplete adjustment for confounders, including those that may 
influence lifestyle and health choices, a mixture of acute and longer-term exposure 
estimates and a lack of enough accounting for attrition (particularly attrition due to 
other health conditions exacerbated by PM2.5).  
Recommendations: The adoption of an agreed standardised data collection, 
processing and analysis protocol and/or a one or two stage individual participant data 
meta-analysis (IPD-MA) to facilitate similar processing across studies. Examination 
of multiple NCD endpoints and analysis, taking account of competing endpoints and 
interactions is also needed, for example, looking at the direct and indirect pathways 
that may impact on dementia risk. 
(2) Limitations that require additional research:  Variation in exposure attribution 
methods between studies, including an absence of detailed compositional 
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information, despite clearly different source profiles between countries, and within 
countries over time.  
Because PM2.5 is not a uniform chemical entity its composition varies markedly 
between different regions [40, 41] as well as across time [40, 41]. Whilst the 
epidemiological literature strongly focuses on PM2.5, it is notable that preliminary work 
and evolving research hypotheses around the potential causal link between air 
pollution and dementia have focused on primary combustion and mechanical 
abrasion particles [39] which represent only a fraction of PM2.5 mass and display 
marked spatial variation, not captured by the simple mass metric. As these fractions 
of PM2.5 are not widely measured in regulatory networks and as models for these 
metrics are relatively recent [42], their association with dementia incidence has not 
been fully explored. This may be of particular importance for cognitive outcomes 
since the ultrafine particulate matter within PM2.5 may translocate across biological 
barriers, for example via olfactory neuron to the olfactory bulb. Often NO2, for which 
widespread monitoring and well validated models are available, is used as a proxy 
for primary exhaust emissions from diesel vehicles, but the literature linking NO2 to 
dementia, or indeed to associated cardiovascular risk factors remains equivocal [2, 
14]. Furthermore, there remain significant gaps in our knowledge of the molecular 
triggers and causal pathways linking poor air quality to increased dementia risk.  
 
Recommendations: We need a better understanding of how PM2.5 composition has 
varied over time and presently varies between different global regions, to fully 
interrogate and integrate studies drawn from different periods and locations. A better 
understanding of these issues will help inform causal inference and potentially 
improve our understanding of the drivers for some of the heterogeneity observed in 
the current evidence base.  
In addition, the extent to which PM2.5 and its constituents, interact with co-pollutant 
gases and volatile organic species in the atmosphere, either additively or  
15 
 
synergistically to impact on the risk of one or more NCDs and  pre-NCD states need 
to be clarified. This is particularly important where one NCD may impact on the risk of 
another, an area where evidence is severely lacking such as for the relationship 
between cardiovascular disease and dementia. [25]. Alongside this we need a 
greater background understanding of the shape of the relationship between PM2.5 
and NCD outcomes and the role of other risk factors. For example, is the relationship 
linear or is there a point at which it has less of an impact (as implied by the recent 
Grande et al study [25])?  
Furthermore, how does the background risk of the population, the life-course 
exposure, and population risk factor habits play a part? Relevant to this is a need to 
better assess personal exposure, to collect data from wider geographical and cultural 
areas and to look by population subgroups where risk levels may vary. For example, 
women may be exposed to increased risk where they are the ones predominantly 
exposed to cooking on woodstoves, or men where they spend more time on busy 
streets outside the home.  
 
(3) Limitations that cannot be easily remedied without new data collection: There 
is bias inherent in the use of administrative health record data, a lack of sophisticated 
cognitive testing and an absence  of long-term follow-up.  
 
Recommendations: An IPD-MA may help in resolving these limitations with the use 
of z-score change for cognition, but inevitably new studies are needed.  
Overall, we can conclude it is likely that greater exposure to PM2.5 increases the risk of 
dementia, and that there is some evidence that this effect is independent of other 
cardiovascular co-morbidities. It is also notable that the magnitude of the relationship 
between incident dementia and PM2.5 after adjustment for co-morbidities is of a similar 
magnitude to that seen for cardiovascular disease. This would imply that the total health 
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impact of ambient PM2.5 may have been significantly underestimated. Understanding the 
potential associations with dementia is therefore critical and whilst the evidence base is 
growing and strengthening, before we can take the next steps and calculate population 
attributable risk, estimate cost implications and model the effects of risk reduction, we need 
a more sophisticated analysis of the current evidence and, ideally, new data collection. Air 
pollution is pervasive and global. It holds numerous inter-related health implications. Using a 
systematic review process to integrate what is already in the literature has allowed us to 
synthesise findings across the breadth of evidence necessary to evaluate such a global 
health phenomena and has allowed important commonalities across these fields to emerge. 
To develop our understanding of the relationship between air pollution and dementia we 
must now look holistically beyond dementia. 
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of systematic 
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Australia 
Pubmed, Web of 
Science, Embase,  
Google Scholar to 
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Not provided. OR1.022 (1.015:1.030) 
I2 61.4% 
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Allied Health 
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Exposure lags 
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Not provided. RR1.011 (1.011:1.012) 
I2 86% 




















and Asia  
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Abbreviations: IQR Inter-Quartile Range, HR Hazard Ratio, NCD Non-communicable Disease, PM2.5 Particulate matter ≤2.5µm in diameter, RR Relative 
Risk, SD Standard Deviation.   
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PM2.5 level  Measures of dementia Measures of air pollution 
exposure 
Results  Adjustments 
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Incident dementia  
Incident dementia from 
general practice records 
(Read codes) and 
dementia listed as 
primary cause of death 
on death certificates 
(International 
Classification of 
Disease version 10) 
Modelled annual 
concentrations of air pollutants 
in the year prior to baseline 
estimated using the KCLurban 
dispersion modelling system at 
a resolution of 20*20 m 
incorporating hourly 
meteorological measurements 
and empirically derived 
concentrations on emissions 
from the London Atmospheric 
Emissions Inventory 
Incident dementia  
PM2.5 HR1.06 
(1.01, 1.13) per 
IQR change 0.95 
µg/m3 increment 




age, sex, ethnicity, 
smoking, body 







heart failure, night 
time noise. Each 
pollutant also 
adjusted for 































Incident dementia  
 
 
Cases ascertained from 
health administrative 
data and defined as 
having one of more 
hospital admission with 
a diagnosis of dementia 
(International 
classification of disease 
versions 9 and 10) or 3 
Annual mean concentration of 
PM2.5 (1 x 1 km) yearly 
between 1998 and 2012. 
Derived from satellite data, 
global atmospheric chemistry 
transport model (GEOS-Chem 
CTM) outputs, and calibrated 




regression. Postal code 
Incident dementia  
5-yr lag: HRIQR = 
1.03 (1.02, 
1.05)Per IQR 4.8 
ug/m3) increment 
 
10-yr lag: HRIQR = 
1.03 (1.01, 1.06) 






% of recent 
immigrants 
pre-existing), urban 





physician claims over a 
two-year period or a 
prescription relating to 
dementia. Note. 
validated algorithm 
applied to health 
insurance database. 
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or residence. 









































































based on the 
Taiwanese National 
Insurance Research 
Database using the 
International 
Classification of 
Disease 9th Revision 
Clinical Modification. 
Taiwan data on PM2.5  only 
available after 2006, hence this 
was extrapolated backwards 
using the mean ratio between 
PM2.5  and PM10 during 2006-
2010. Annual average PM10 
according to guidance from 
USA EPA. Data from 70 EPA 
sites across Taiwan at 
postcode level, interpolated 
using inverse distance weight 
method. 
Incident AD  
HR1.03 (0.95:1.11) 
per IQR (13.21 
ug/m3) increment 
of baseline PM2.5  
HR2.38 (2.21:2.56) 
per IQR (4.34 
ug/m3) increase in 

















Incident AD defined as 
individuals who had 
received at least 2 
consensus diagnoses 
between 2001 and 
2010. Diagnoses are 
assigned by physicians 
based on history, 
physical examination, 




ADRDA, or Hachinski 
ischemic scores 
change in PM2.5  
during follow up. 
Similar results 
when adjusted for 
other pollutants.   
multiple (PM10, O3, 

































Incident dementia  








alongside clinical data 
and physician 
assessment used by a 
central blinded 
adjudication committee 
to reach a dementia 
diagnosis  
Diagnostic criteria 
DSM-IV   
 
Yearly time series of PM2.5  
exposure generated from 
statistically validated Bayesian 
Maximum Entropy method 
(BME) estimates applied to 
geocoded residential location 
and combined with residential 
histories to calculate the 3-y 
moving average exposure. 
BME method used to construct 
spatiotemporal models to 
estimate ambient 
concentrations of PM2.5  which 
integrates nationwide 
monitoring data from the US 
EPA AQS and output of 
chemical transport models to 
characterize spatiotemporal 
interdependence of 
environmental data to estimate 
mean trends and covariance of 
Incident dementia.  



























































Incident dementia  
Dementia was 
assessed at baseline 
and every 5 years using 
medical records from 
hospital and primary 
care visits over the 5 
year period plus 
observations obtained 
at Betula study visits 
(health and cognitive 
evaluations). Extended 
review by a senior Old 
age psychiatrist was 
included in Mini-Mental 
State Exam scores 
were ≤23 or where 
cognitive or functional 
status had declined 
from previous visit or 
where a participant 
expressed a perception 
of subjective memory 
loos or where cognitive 
or behavioural issues 
were noticed by the 
testing team. A quality 
assurance exercise with 
blinded re-evaluation.  
Diagnostic criteria 
DSM-IV   
 
Note. Blinded re-
evaluation was made of 
Used annual mean 
concentration of PM2.5  for 
1990, 2000, 2010 calculated by 
the Swedish Meteorological 
and Hydrological Institute which 
estimated concentrations using 
a wind model and a Gaussian 
air quality dispersion model. To 
estimate PM2.5  from vehicular 
emissions the traffic flow for 
vehicles was collected for most 
major roads and modelled for 
elsewhere. Vehicle fleet 
composition derived from 
national vehicle registry, and 
emission factors for exhaust 
calculated based on the 
Handbook Emission Factors for 
Road Transport. Model grids 
were of 3200 m x3200 m 
spatial resolution and 50 m x 
50 m in urban areas 
Incident dementia  
HR=1.14 (0.59, 














medical records of 











years prior to 
baseline, 















Based on residential addresses 
with dispersion modelling 
based on local emission 
inventories. Gaussian 
dispersion model was applied 
to the emission databases with 
meteorological and climate 
data and using a quadtree 
receptor grid to allow high 
resolution in the vicinity of 
roads. Time varying 5-year 
mean Pm2.5 
HR 1.54 
(1.33:1.78) per IQR 
difference of 0.88 
µg/m3 
Authors also report 
a non-linear 
relationship such 
that the increase in 
risk was steepest 
from low to mean 
level 
concentrations and 















disease as a 
moderating or 
mediating factor 
and reported PM2.5 
associated with a 
stroke – dementia 










































From hospital record 
ICD-9 coding, or 3 
physician medical 
services claims in 3 
years, or prescriptions 
for acetylcholinesterase 
inhibitors. Divided 
cases in non-Alzheimer 
dementia and 
Alzheimer’s Dementia.  
Based on residential address 
and satellite-based estimation 
of PM2.5 based on land use 
regression models. There were 
25 monitoring sites for PM2.5 























Disease, due to 
small numbers, 
analysis was via an 








Abbreviations: EPA AQS United States Environmental Protection Agency Air Quality System, BMI Body Mass Index, CO2 Carbon dioxide, DSM-IV Diagnostic 
Statistical Manual for mental disorders, IQR Inter-Quartile Range, HR Hazard Ratio, MMSE Mini-Mental State Exam, NINCDS ADRDA National Institute of 
Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association, O2 Nitrogen dioxide, NCD Non-
communicable Disease, O3 Ozone, PM2.5 Particulate Matter ≤2.5µm in diameter, PM10 Particulate Matter ≤10µm in diameter, RR Relative Risk, SD Standard 
Deviation, SES Socioeconomic Status, SO2 Sulphur dioxide.   
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Table 3 PM2.5 as a risk factor for cognitive decline 
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exposure 
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Measures of air pollution 
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Results  Adjustments 
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et al 
























(averaged z scores 
from TICS 10-word 
list, EBMT, 
immediate recall, 









exposure from 1988 through 
to month preceding month) 
preceding baseline cognitive 
interview. Derived from 
EPA's AQS meteorological 
data and GIS smoothing 
models for geocoded 
residential location per 
participant. 
Adjusted 
difference in 2-yr 











term physical activity, long-
term alcohol consumption, 
time x covariate 
interactions (BMI, diabetes, 
smoking, aspirin use, 
ibuprofen use adjustments 
had no effect) 
Further adjustment in 
secondary analyses found 
similar results. 
Secondary analyses: SES 
measures (percentage of 
adults who have less than 
high school education, 
median home value, 
median income) 
Additional analyses: self-
reported emphysema and 
indicators of cardiovascular 
and cerebrovascular 
disease (high blood 
pressure, coronary heart 
disease, congestive heart 
failure, coronary artery 
bypass graft, transient 











up to and 
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9.2) 
Quartiles 
















Annual average exposure 
using an algorithm 
combining EPA's AQS 
ground level monitoring data 
and NASA's MODIS aerosol 
optical depth satellite data to 
calculate daily PM2.5  
exposure per participant 
according to residence up to 




increase in PM2.5  
>12 months, n = 
18180 
OR =0.71 (0.38, 
1.32) 
Length of follow up, 
temperature, season, 
incident stroke, age, race, 
region, education, income, 
behavioral factors (alcohol, 
smoking, exercise, body 






















Tests of reasoning 
(Alice Hein 1-I test) 
Short term verbal 
memory (20-word 











converted to z 
scores and 
standardized using 
distribution of that 
wave. Linear mixed 







concentration for years 
2003-2009 modelled at 
resolution 20 x 20 m using 
the KCLurban dispersion 
modelling system which 
incorporates meteorological 
data, empirically derived 
PMrelationships and 
emission from the London 
Atmospheric Emission 
Inventory. Exposure at 
residence based on average 
concentration at model grid 
points within 25 m of the 
postcode centre. 
5-y average (preceding 










fluency per IQR 
increase 
5-y average: ns 
for all tests 
Age, sex, ethnicity, marital 
status, education, SES 
(civil service employment 
grade), alcohol use, 
physical activity, time, age 
x time interaction, main 











Change in MMSE, 
CDR-SB 
Annual mean concentrations 
derived daily 24-hour PM2.5  
Ns Age, gender, education, 













































(1.3±0.02 on the 
MMSE and 
1.0±0.02 on the 
CDR-SB (mean ± 
std. error of the 
mean)) is provided 
only for the whole 
cohort – ie including 
those with baseline 
MMSE >26 and 26 
and below.  
concentrations in µg/m3 
starting year before 
baseline. 
EPA’s hierarchical Bayesian 
model data derived from 
ground-level monitoring data 
from the AQS and simulated 
ozone and from the CMAQ 
model (estimates available 
in 12x12 m resolution 
covering eastern states and 
24 x 24 m nationwide) used. 
Yearly exposure estimates 
based on to ZIP codes of 





PM2.5  interaction 
and cognitive 
decline. Lowest 
decline in those 
without APOE4 
allele and lowest 
exposure 
smoking, B12 deficiency 



































decline in global 
cognitive function 
(operationally 
defined as having 
an 8-point loss in 
the Modified MMSE 




Yearly time series of PM2.5  
exposure generated from 
statistically validated 
Bayesian Maximum Entropy 
method (BME) estimates 
applied to geocoded 
residential location and 
combined with residential 
histories to calculate the 3-y 
moving average exposure. 
BME method used to 
construct spatiotemporal 
models to estimate ambient 
concentrations of PM2.5  
which integrates nationwide 
monitoring data from the US 
EPA AQS and output of 
chemical transport models to 
characterize spatiotemporal 
interdependence of 
environmental data to 
estimate mean trends and 















Age, geographic location, 
education, income, 
employment status, 
lifestyle factors (smoking, 
alcohol, physical activity), 
clinical characteristics (use 
















































Change scores for 
reasoning, reaction 




and were analysed 
with linear 
regression;  
Change on the 
prospective memory 
test was analysed 
using logistic 
regression,  
Measures were modelled at 
participants’ baseline 
residential addresses.  PM2.5  
was measured as annual 
average values in μg/m3. 
Estimates for the year 2010 
were modelled for each 
address using a Land Use 
Regression model 
developed as part of the 
European Study of Cohorts 
















when p value 








Duration between baseline 
and 
follow-up as well as 
baseline age, gender, 
ethnic group, Townsend 
score (socioeconomic), 
education, 
smoking status, physical 
activity time outdoors, 
major road proximity, traffic 




























and domain specific 
cognitive scores 
from a neuropsych 
battery combined 





mixed models for 
repeated measures  
 
Estimates of residential 
ambient air pollution levels in 
the calendar year prior to 
first neuropsychological 
assessment  were from the 
U.S. Environmental 
Protection Agency (EPA) Air 
Quality System and annual 
average values were used in 
a universal kriging 
regression framework to 
predict concentrations at 
individual addresses. Partial 
least square methods were 













Visit number, visit by 




socioeconomic status, and 
an indicator for cohort 
wave to account for 
secular trends.  
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covariates (roadway density, 
population density, urban 
land, agricultural land, 
forests, bodies of water), 
land use, and roadway 
proximity to improve 
predictions 
 
Abbreviations: CDR-SB Clinical Dementia Rating Scale–Sum of Boxes, CMAQ Community Multiscale Air Quality Modelling System, GIS geographic 
information system EBMT East Boston Memory Test,  EPA AQS United States Environmental Protection Agency Air Quality System, BMI Body Mass Index, 
CO2 Carbon dioxide, DSM-IV Diagnostic Statistical Manual for mental disorders, IQR Inter-Quartile Range, HR Hazard Ratio, MMSE Mini-Mental State Exam, 
NASA MODIS NASA Moderate Resolution Imaging Spectroradiometer, NINCDS ADRDA National Institute of Neurological and Communicative Disorders and 
Stroke and the Alzheimer's Disease and Related Disorders Association, O2 Nitrogen dioxide, NCD Non-communicable Disease, O3 Ozone, PM2.5 Particulate 
Matter ≤2.5µm in diameter, PM10 Particulate Matter ≤10µm in diameter, RR Relative Risk, SD Standard Deviation, SES Socioeconomic Status, SO2 Sulphur 
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Flow diagram, original research on incident dementia, Alzheimer’s 
Disease, cognitive decline  and particulate matter 2.5  
Flow diagram, systematic reviews of major non-communicable 
disease incidence and particulate matter 2.5 
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